https://www.vox.com/health/23826023/wegovy-ozempic-heart-disease-attack-stroke-death-lower-risk-diabetes
A clinical trial suggests the popular diabetes and weight loss drug semaglutide (branded as Wegovy and Ozempic) reduced the risk of serious heart problems by 20 percent.
Create an account or login to join the discussion